|
CNP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.445600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.332200E-01 |
| Normal-vs-Stage2 |
1.341190E-01 |
| Normal-vs-Stage3 |
1.066220E-01 |
| Normal-vs-Stage4 |
1.983350E-03 |
| Stage1-vs-Stage2 |
3.527400E-01 |
| Stage1-vs-Stage3 |
3.278200E-01 |
| Stage1-vs-Stage4 |
3.475200E-03 |
| Stage2-vs-Stage3 |
9.690200E-01 |
| Stage2-vs-Stage4 |
1.309960E-01 |
| Stage3-vs-Stage4 |
1.400250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.651000E-01 |
| Normal-vs-AfricanAmerican |
1.998090E-02 |
| Normal-vs-Asian |
1.274610E-01 |
| Caucasian-vs-AfricanAmerican |
3.885600E-02 |
| Caucasian-vs-Asian |
3.481000E-01 |
| AfricanAmerican-vs-Asian |
5.341800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.146800E-01 |
| Normal-vs-Female |
3.272800E-01 |
| Male-vs-Female |
7.719200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.505000E-01 |
| Normal-vs-Extreme_Weight |
5.195000E-01 |
| Normal-vs-Obese |
3.066200E-01 |
| Normal-vs-Extreme_Obese |
5.801200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.898800E-01 |
| Normal_Weight-vs-Obese |
6.557200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.666000E-01 |
| Extreme_Weight-vs-Obese |
7.167000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.177800E-01 |
| Obese-vs-Extreme_Obese |
9.380600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.403600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.470400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.033500E-02 |
| Normal-vs-Age(81-100Yrs) |
3.289700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.764800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.799400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.540580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.484300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.052160E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.158800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.411000E-01 |
| Normal-VS-Type2 PRCC |
1.162570E-03 |
| Normal-VS-KIRP CIMP |
3.192200E-04 |
| Normal-VS-Unclassified PRCC |
9.082500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.85470000036281E-07 |
| Type1 PRCC-VS-KIRP CIMP |
3.49480000050306E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
4.819900E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.163000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.390000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.855200E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.068500E-02 |
| Normal-vs-N1 |
2.638900E-03 |
| Normal-vs-N2 |
2.622800E-01 |
| N0-vs-N1 |
1.121590E-01 |
| N0-vs-N2 |
6.524600E-01 |
| N1-vs-N2 |
8.335200E-01 |
|
|
